» Articles » PMID: 9851787

Molecular Genotyping in Brazilian Patients with the Classical and Nonclassical Forms of 21-hydroxylase Deficiency

Overview
Specialty Endocrinology
Date 1998 Dec 16
PMID 9851787
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of our study was to determine, by allele-specific PCR, the frequency of point mutations in 130 Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency and to correlate genotype with phenotype. The most frequent mutations were 12 splice (41.8% in salt wasting), I172N (32.6% in simple virilizing), and V281L (40.2% in late onset form). The frequency of the 9 most common point mutations was similar to that reported for other countries, except for Del 8 nt and Cluster, which were less frequent in the classical form. Rarer mutations such as P453S, G291S, I7 splice, W405X, R483P, and R483-->frameshift were rarely found or were absent. The 93 fully genotyped patients were classified into 3 mutation groups, based on the degree of enzymatic activity (group A, <2%; group B, approximately 2%, and group C, >18%). In group A, 62% of the cases presented the salt wasting form; in group B, 96% the simple virilizing form; and in group C, 88% the late onset form. We diagnosed 80% of the affected alleles after screening for large rearrangements and 15 point mutations. The absence of previously described mutations in 20% of the affected alleles suggests the presence of new mutations in our population.

Citing Articles

CONGENITAL ADRENAL HYPERPLASIA WITH COMPOUND HETEROZYGOUS I2 SPLICE AND P453S MUTATIONS.

Almacan B, Ozdemir N, Onay H, Hekimsoy Z Acta Endocrinol (Buchar). 2022; 18(2):228-231.

PMID: 36212252 PMC: 9512366. DOI: 10.4183/aeb.2022.228.


Low Adrenomedullary Function Predicts Acute Illness in Infants With Classical Congenital Adrenal Hyperplasia.

Weber J, Tanawattanacharoen V, Seagroves A, Liang M, Koppin C, Ross H J Clin Endocrinol Metab. 2021; 107(1):e264-e271.

PMID: 34397083 PMC: 8826013. DOI: 10.1210/clinem/dgab600.


Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia.

Lousada L, Mendonca B, Bachega T Arch Endocrinol Metab. 2021; 65(4):488-494.

PMID: 34283908 PMC: 10522175. DOI: 10.20945/2359-3997000000392.


Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Claahsen-van der Grinten H, Speiser P, Ahmed S, Arlt W, Auchus R, Falhammar H Endocr Rev. 2021; 43(1):91-159.

PMID: 33961029 PMC: 8755999. DOI: 10.1210/endrev/bnab016.


Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Kocova M, Anastasovska V, Falhammar H Endocrine. 2020; 69(2):262-277.

PMID: 32367336 PMC: 7392929. DOI: 10.1007/s12020-020-02323-3.